4.jpg 6.jpg

Who We Are?

Plumino founded in

2025

Founded in 2025, the company specializes in the research, development and production of amino acid derivatives and human milk oligosaccharides (HMOs), with a number of patents on its core technologies, and its products serve customers in the pharmaceutical, nutritional health and scientific research fields in many countries around the world.

News & Updates

Plumino has acquired the pharmaceutical, food and feed-grade, amino acids, and Human Milk Oligosaccharides (HMOs) businesses and related assets from Kyowa Hakko Bio Co., Ltd.

Kyowa Hakko Bio, established on October 1, 2008, traces its origins to the Biochemical Division of Kyowa Hakko Kogyo Co., Ltd. founded in 1949. As a pioneer in amino acid fermentation technology, Kyowa Hakko Bio specialized in producing high-purity, pharmaceutical-grade amino acids through advanced fermentation processes for extensive applications in pharmaceuticals and healthcare.

Leveraging Kyowa Hakko Bio’s 70+ years of technological expertise, Plumino will continue to explore biotechnology frontiers. We are poised to drive innovation and excellence in biotechnology and amino acid research, continually expanding the possibilities within the life science industry

d1_img01.jpg

Global presence with local reach

d1_img02.svg
Plumino Precision Fermentation USA, Inc. Plumino Precision Fermentation Europe GmbH Plumino Precision Fermentation Japan Co., Ltd. Plumino Biotechnology (Guangdong) Co., Ltd.
Shanghai Plumino Amino Acid Co.,Ltd. Plumino Precision Fermentation Holdings Pte. Ltd. Plumino Biotechnology Singapore Pte. Ltd. Plumino USA, Inc. Plumino Precision Fermentation (Thailand) Co., Ltd
  • d1_icon02.svg

    Parent company & Sales companies

  • d1_icon01.svg

    Production sites

  • d1_icon01l.svg

    Sales companies

  • 3Production sites d1icon1.svg

  • 5Sales companies d1icon2.svg